December 20, 2024

Pairing live support with accurate AI outputs

A live agent spends hours each week manually documenting routine interactions. Another combs through multiple knowledge bases to find the right solution, scrambling to piece it together while the customer waits on hold. A third types out the same response they’ve written dozens of times before. These repetitive tasks can be draining, leaving less time…

Beeper acquired by Automattic, fintech’s decline and YC’s lack of LatAm founders

April 12, 2024

When it comes to news items that we love at TechCrunch, IPOs rank pretty darn high. Another great newsy bit that comes along less frequently than we’d like is a startup buying another startup. These deals are often very interesting as they either bring a gob of talent, or technology to an already growing company, […]

© 2024 TechCrunch. All rights reserved. For personal use only.

5 reasons to attend TC Early Stage 2024

April 12, 2024

TechCrunch Early Stage 2024 isn’t just another tech startup event — it’s the destination for early-stage startups to get hands-on, actionable insights to scale their business directly from expert leaders. Here are five amazing reasons why you need to mark your calendar for April 25 and secure your spot at this groundbreaking event in Boston. […]

© 2024 TechCrunch. All rights reserved. For personal use only.

The Download: a history of brainwashing, and America’s chipmaking ambitions

April 12, 2024
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology A brief, weird history of brainwashing On a spring day in 1959, war correspondent Edward Hunter testified before a US Senate subcommittee investigating “the effect of Red China Communes on the United States.”…

3 Affordable Pharma Stocks to Buy for Portfolio Gains

April 12, 2024
The pharmaceutical market is anticipated to grow substantially in the upcoming years, owing to technological innovation and rising demand for personalized medicines. To that end, affordable pharma stocks ACADIA Pharmaceuticals…

The effort to make a breakthrough cancer therapy cheaper

April 12, 2024
This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here.  CAR-T therapies, created by engineering a patient’s own cells to fight cancer, are typically reserved for people who have exhausted other treatment options. But last week, the FDA…

A brief, weird history of brainwashing

April 12, 2024
On an early spring day in 1959, Edward Hunter testified before a US Senate subcommittee investigating “the effect of Red China Communes on the United States.” It was the kind of opportunity he relished. A war correspondent who had spent considerable time in Asia, Hunter had achieved brief media stardom in 1951 after his book…